AstraZeneca’s Phase I / II Covid-19 vaccine trial unlikely to report convincing protection data

Cobertura de los medios

• Nombre	AstraZeneca’s Phase I / II Covid-19 vaccine trial unlikely to report convincing protection data
  Nombre/canal del medio de comunicación	Pharmaceutical Technology
  País/Territorio	Estados Unidos
  Fecha	27/8/20
  URL	https://www.pharmaceutical-technology.com/comment/astrazeneca-covid-19-vaccine-trial/
  Personas	Ira Longini